arrow-circle-full-right arrow-circle-full-up arrow-circle-up arrow-down arrow-right calendar calendar-done facebook flickr home linkedin login pin reload search share signin star twitter video video youtube nav star-plus info signout double-arrow arrow-up checked
Healthcare & Life Sciences

FT Digital Health Summit USA 2015

Mapping the Path for Commercial Delivery

New York |
Speakers include:
Daniel Kraft

Daniel Kraft

Singularity University

Laurie Olson

Laurie Olson


Deborah  Waterhouse

Deborah Waterhouse



Mapping the Path for Commercial Delivery

Digital health is now seeing a rapidly growing array of innovative technologies and applications which are starting to grab consumer attention, especially as the larger, more established corporations move into this space. These advancements are showing that the industry will inevitably give rise to greater investment and business opportunities. 

However, the map showing the path to healthcare’s effective digital transformation is not entirely clear and small tech companies and venture capitalists still dominate the market. Commercial business models, reimbursement methods and market-wide consumer acceptance still need to be identified and proven and as with other industries before digital health, regulation will undoubtedly play a key role in allowing this to happen. 

The FT Digital Health Summit USA will build upon the Financial Times' expertise and knowledge of healthcare, life sciences and digital business to set out a stakeholder roadmap for upscaling America’s digital health industry, which in terms of investment, innovation and market share is far ahead of any other region. Key figures from throughout the healthcare, technology and investment arena will come together to set the agenda for overcoming the barriers towards a sustainable digital transition of US healthcare.

fallback Add to my Calendar 10/28/2015 08:00:0010/28/2015 17:30:00trueFT Digital Health Summit USA 2015Mapping the Path for Commercial DeliveryDigital health is now seeing a rapidly growing array of innovative technologies and applications which are starting to grab consumer attention, especially as the larger, more established corporations move into this space. These advancements are showing that the industry will inevitably give rise to greater investment and business opportunities. However, the map showing the path to healthcare’s effective digital transformation is not entirely clear and small tech companies and venture capitalists still dominate the market. Commercial business models, reimbursement methods and market-wide consumer acceptance still need to be identified and proven and as with other industries before digital health, regulation will undoubtedly play a key role in allowing this to happen. The FT Digital Health Summit USA will build upon the Financial Times' expertise and knowledge of healthcare, life sciences and digital business to set out a stakeholder roadmap for upscaling America’s digital health industry, which in terms of investment, innovation and market share is far ahead of any other region. Key figures from throughout the healthcare, technology and investment arena will come together to set the agenda for overcoming the barriers towards a sustainable digital transition of US healthcare.FT-Digital-Health-Summit-USA-201550fbff304ffb9b82e6801804797c81e3MM/DD/YYYY

FT Digital Health Summit USA Brochure

Download Brochure

Speakers (23)

Daniel Kraft

Daniel Kraft

Faculty Chair Medicine and Neuroscience
Singularity University

Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator.  Dr Kraft has over 25 years of experience in clinical practice, biomedical research and healthcare innovation.  He has chaired the Medicine track for Singularity University  since its inception in 2008, and is Founder and Executive Director of Exponential Medicine, a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare.

Following undergraduate degrees from Brown University and medical school at Stanford, Dr Kraft was Board Certified in both Internal Medicine and Pediatrics after completing a Harvard residency at the Massachusetts General Hospital & Boston Children's Hospital, and fellowships in hematology, oncology and bone marrow transplantation at Stanford.   He has multiple scientific publications and medical device, immunology and stem cell related patents through faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at University of California San Francisco.

Dr Kraft is a member of the Kaufman Fellows Society (Class 13) and member of the Inaugural (2015) class of the Aspen Institute Health Innovators Fellowship.

He is also the inventor of the MarrowMiner, an FDA approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell based regenerative therapies. Dr Kraft is an avid pilot and has served in the Massachusetts and California Air National Guard as an officer and flight surgeon with F-15 & F-16 fighter Squadrons. He has conducted research on aerospace medicine that was published with NASA, with whom he was a finalist for astronaut selection.

Laurie Olson

Laurie Olson

Executive Vice President - Strategy, Portfolio and Commercial Operations

Laurie Olson is Executive Vice President of Strategy, Portfolio and Commercial Operations of Pfizer. She is responsible for overseeing the shaping of Pfizer’s longer-term strategy, supporting the execution for Pfizer’s commercial objectives, and providing portfolio advisory functions to guide R&D investment decisions. Ms Olson is a member of Pfizer’s Executive Leadership Team and also a member of the Portfolio Strategy Investment Committee, which oversees decisions regarding enterprise portfolio investment and advancement. Ms Olson joined Pfizer in 1987 as an Analyst in the company’s Marketing Research organisation. She has since held both US and global leadership roles in marketing, commercial development, strategy, analytics and operations. In her most recent role as Senior Vice President, Portfolio Management and Analytics, she served on an executive task force that successfully redesigned Pfizer’s R&D organisation to strengthen its pipeline and improve efficiency. In 2011, Corporate Strategy was added to her responsibilities. In addition to her daily responsibilities, she is the executive sponsor of Pfizer’s global Lesbian, Gay, Bisexual, and Transgender Colleague Council and serves on the company’s worldwide Diversity Leadership Council. Ms Olson earned a Bachelor of Science degree in Economics from the State University of New York at Stony Brook and an MBA in Marketing from Hofstra University.

Deborah  Waterhouse

Deborah Waterhouse

Senior Vice President - Primary Care

Deborah Waterhouse began her career with GlaxoSmithKline (GSK) in 1996. Since then, she has progressed through increasingly senior positions in Sales, Marketing, Human Resources and Research and Development, in the UK, Europe, US and Australasia.  

Ms Waterhouse became General Manager of GSK Australia and New Zealand in August 2008, when she, her husband and two young children moved to Melbourne. She moved back to Europe as Senior Vice President (SVP) and Regional Head of Central Europe which comprises of 22 countries with more than 2000 employees, generating sales revenue of £1.2bn.  

She moved with her family to Philadelphia to take up the role of SVP and Business Head US Vaccines. In September 2013 Ms Waterhouse was appointed SVP Vaccines Business Unit US Pharmaceuticals leading a team of 600 people and $2bn revenue. She has recently been appointed SVP Primary Care leading the Respiratory, General Medicine and Strategy, Planning & Operations teams. She has accountability for over 3000 GSK colleagues and $5bn in revenue.

Ms Waterhouse has worked for almost 10 years with a number of organisations supporting the advancement of women in the workplace.  In 2010 and 2011 GSK Australia was awarded Employer of Choice for Women. In 2011 she was given a Directors Award by the Australian Government for her work supporting equality for women in the workplace.  

Babak  Parviz

Babak Parviz

Vice President

Babak Parviz is a Vice President at Amazon. He is the creator of Google Glass, a pioneer of human-machine and human-environment interface design, and has been active in developing computing and medical devices for a number of years. He received his BA in Literature from University of Washington, BS in Electronics from Sharif University of Technology, MS degrees in Electrical Engineering and Physics from University of Michigan and a PhD in Electrical Engineering from University of Michigan. He completed his postdoctoral fellowship in Chemistry and Chemical Biology at Harvard University.

Dr Parviz’s interests span novel computing and communication paradigms, high-tech with social impact, bionanotechnology, and photonics. His work has been put on display at the London Museum of Science and has received numerous recognitions and awards including NSF Career Award, MIT TR35, Time magazine’s best invention of the year (2008 and 2012), Your Health Top 10 Medical advance of the year, and top invention and has been reported on in thousands of articles worldwide. In 2012 he was selected by Ad Age as one of the 50 most creative people in the United States.

Andrew  Racine

Andrew Racine

Senior Vice President and Chief Medical Officer, Montefiore Medical Center & Executive Director
Montefiore Medical Group

Andrew Racine is the Senior Vice-President and Chief Medical Officer of the Montefiore Medical Center and Executive Director of the Montefiore Medical Group. He has appointments as Professor of Clinical Pediatrics at the Albert Einstein College of Medicine (AECOM) and Research Associate at the National Bureau of Economic Research (NBER) in Manhattan.

Dr Racine holds combined degrees in medicine and economics having received his M.D. and Ph.D. from New York University as a National Research Service Award scholar from 1975-1983. He subsequently trained in pediatrics at the Boston Children’s Hospital before returning to New York City to serve on the faculty of Columbia University College of Physicians and Surgeons. In 1992 Dr Racine was recruited from Columbia to become the Associate Director of the Division of General Pediatrics at AECOM. He served as Director of the Division of General Pediatrics from 1997 until August of 2012 when he assumed his new positions.

His research collaborations at the NBER have involved the impact of a variety of public health programs on child health. He has also been heavily involved in child health advocacy at the national level with the American Academy of Pediatrics and serves on the AAP’s national Committee on Child Health Financing.

Harry Leider

Harry Leider

Chief Medical Officer and Group Vice President
Bakul Patel

Bakul Patel

Associate Director for Digital Health
US Food and Drug Administration (FDA)

Bakul Patel is Associate Director for Digital Health, at the Center for Devices and Radiological Health (CDRH), at the Food and Drug Administration (FDA).  Mr Patel leads regulatory policy and scientific efforts at the Center in areas related to emerging and converging areas of medical devices, wireless and information technology. This includes responsibilities for mobile health, health information technology, cyber security, medical device interoperability, and medical device software.  

Mr Patel is the FDA liaison between the Federal Communications Commission (FCC) and the Office of the National Coordinator (ONC). Since its inception in 2013, he chairs the International Medical Device Regulators Forum (IMDRF) “software as a medical device” working group, a global harmonization effort.

Before joining FDA, Mr Patel held key leadership positions working in the telecommunications industry, semiconductor capital equipment industry, wireless industry and information technology industry. Mr Patel’s experience includes Lean Six Sigma, creating long and short-term strategy, influencing organizational change, modernizing government systems, and delivering high technology products and services in fast-paced, technology-intensive organizations.

Mr Patel earned an MS in Electronic Systems Engineering from the University of Regina, Canada, and an MBA in International Business from The Johns Hopkins University.

David Rhew

David Rhew

Chief Medical Officer and Head of Healthcare and Fitness
Samsung Electronics America

David Rhew is the Chief Medical Officer (CMO) and Head of Healthcare and Fitness for Samsung Electronics America.  Dr Rhew received his Bachelors of Science degrees in computer science and cellular molecular biology from the University of Michigan. He received his MD degree from Northwestern University and completed internal medicine residency at Cedars-Sinai Medical Center. He completed fellowships in health services research at Cedars-Sinai Medical Center and infectious diseases at the University of California, Los Angeles.

Dr Rhew has served as CMO and Vice-President for Global Healthcare at Samsung SDS; Senior Vice-President and CMO at Zynx Health Incorporated; clinician/researcher in the Division of Infectious Diseases at the VA Greater Los Angeles Healthcare System; and Associate Clinical Professor of Medicine at UCLA. Dr Rhew has served on the National Quality Forum’s (NQF) Steering Committee for Pulmonary and Critical Care quality indicators and is currently on the NQF Consensus Standards and Approval Committee. He co-holds six U.S. technology patents that enable the authoring, mapping, and integration of clinical decision support into the electronic health record.

Dr Rhew’s interests include measurably improving the quality, safety, and efficiency of patient care and applying technology to engage patients and consumers in their health care.

Halle  Tecco

Halle Tecco

Founder and Managing Director
Rock Health

Halle Tecco is a Founder and Managing Director of Rock Health, the first seed fund devoted exclusively to digital health companies. She is also an angel investor with Techammer, which has made over 40 investments in technology companies including Misfit Wearables, Quora, and Kaggle.
She has appeared in The New York Times, The Wall Street Journal, and CNBC. She was named on the Forbes 30 under 30 list as well as Goldman Sach’s Most Intriguing Entrepreneurs. She has an MBA from Harvard Business School.

Alan Muney

Alan Muney

Chief Medical Officer

Alan Muney joined Cigna in 2010 as Senior Vice President in charge of Total Health & Network, the company’s health management and contracting organization. He was named Chief Medical Officer in 2011 and leads Cigna's efforts to ensure its customers worldwide achieve the best possible personal health and wellness through programs and services they receive from Cigna.

Dr Muney has nearly three decades of experience leading health plan operations and in medical group practice management. Prior to joining Cigna, he was an executive director at The Blackstone Group where he was CEO and founder of Equity Healthcare. Prior to that, he held positions at Oxford Health Plans, UnitedHealthcare, Avanti Health Systems of NYLCare, and Mullikin Medical Centers in California. Dr Muney received both his bachelor’s and medical degrees from Brown University and completed his internship, residency and fellowship in pediatrics at Washington University Medical Center in St. Louis. He earned a master’s degree in healthcare administration from the University of La Verne in La Verne, Calif.  Dr Muney is licensed to practice in Connecticut, New York and California and is board-certified in pediatrics.

Harry Greenspun, M.D.

Harry Greenspun, M.D.

Deloitte Center for Health Solutions

Harry Greenspun, M.D. is the Senior Advisor for Health Care Transformation & Technology at the Deloitte Center for Health Solutions (DCHS), part of Deloitte LLP (United States). He has held a diverse range of clinical and executive roles, and is now responsible for helping Deloitte’s health care, life sciences, and government clients address key health information technology (IT) and clinical transformation issues. Prior to joining Deloitte, he served as Chief Medical Officer for Dell Inc, after serving as Chief Medical Officer for Northrop Grumman Corporation. Distinguished co-author of Reengineering Health Care: A Manifesto for Radically Rethinking Health Care Delivery, Dr Greenspun is recognized as a leader in the health care industry and has been named one of the “50 Most Influential Physician Executives in Healthcare” by Modern Healthcare. He serves on the World Economic Forum’s Global Agenda Council on Digital Health, and has served on advisory boards for the Healthcare Information and Management Systems Society (HIMSS), Tufts University, George Mason University, and Bloomberg/BNA.As the Chairman of the HIMSS Government Relations Roundtable and as co-chair of the HIMSS task force responsible for creating the white paper entitled Enabling Healthcare Reform Using Information Technology, Dr Greenspun has made recommendations to the Obama Administration and US Congress on the importance of healthcare IT investment to the nation. Dr Greenspun received his Bachelor’s degree from Harvard University, his medical degree from the University of Maryland, and completed his residency and fellowship at the Johns Hopkins University Hospital in Anesthesiology and Critical Care Medicine, serving as Chief Resident. As a cardiac anesthesiologist, he has practiced in major academic medical centers, as well as community hospitals.

Unity Stoakes

Unity Stoakes

Co-founder and President
StartUp Health

Unity Stoakes is on a mission to reinvent health and wellness by leveraging the power of networked entrepreneurs, innovation, technology, data, design, collaboration and community. Unity is the Co-founder and President of StartUp Health, which is organizing and supporting a global army of Health Transformers. With more than 350 Healthcare Transformers and 200 companies, StartUp Health spans more than a dozen countries and 60 cities.
Unity has been a technology entrepreneur since the mid-nineties, previously co-founding OrganizedWisdom and helping build The Privacy Council, Middleberg Interactive and, which he helped take public on NASDAQ with his business partner of 20 years, Steven Krein. 

Unity is a contributing writer for Forbes and has been a guest on Bloomberg TV, CNBC and USA Today. He is also the host of StartUp Health NOW, a weekly web show on the entrepreneurs and changemakers reimagining health.  Unity is a founding member of the Society of Participatory Medicine and on the AARP Innovation @50+ Advisory Board, the SXSW Accelerator Advisory Board and Care Innovations Advisory Board. He received his BA in Communications and Political Science from Boston University.

Jody Holtzman

Jody Holtzman

Senior Vice President, Market Innovation

Jody Holtzman has over twenty-five years of experience helping companies develop and implement competitive strategies and achieve their strategic market goals, Jody now leads the Market Innovation group for AARP, where he brings a non-traditional perspective to the field of aging shaped by a 20-year career in strategy, innovation, and organizational change.

At AARP, Jody is focused on ways to spark innovation in the market to benefit people over 50. In this role he envisioned and developed the concept of the $7.6 trillion Longevity Economy; co-founded and launched the Longevity Network,, with United Healthcare; and, created the Innovation@50+ LivePitch franchise which has attracted over 1,000 applicants and seen 27 out of the first 50 finalists raise over $175 million in venture investment.

Jody’s work has been published in Venture Capital Review, the Journal of Business Strategy, Competitive Intelligence Magazine, the Competitive Intelligence Anthology, and Making Cents Out of Knowledge Management. He has a graduate degree in international political economy from the University of Chicago.

Lucian  Iancovici

Lucian Iancovici

Investment Manager - Qualcomm Life Fund
Qualcomm Ventures

Lucian Iancovici is a Management Member at dRx Capital, and he also serves as an Investment Manager at Qualcomm Ventures, who makes investments through Qualcomm’s Life Fund. His background and experience in medicine lead him to believe that this is a transformative period in the healthcare space, especially given the renewed interest in performance and cost metrics prevalent today. In this context, Dr Iancovici is focused on wireless healthcare opportunities.  He has led investments in Practice Fusion. Edico Genome,  and Predalytics (Aquired by Welltok), and worked closely with Fitbit, ClearCare, and Telcare.

Previously, Dr Iancovici worked at McKinsey & Company, where he spent most of his time in the North American healthcare practice advising on clinical and business model transformation for large hospital systems. Prior to McKinsey, he was a board certified internal medicine doctor practicing in New York. Dr Iancovici trained in internal medicine at Columbia University Medical Center in New York and completed both medical school and his undergraduate studies at Tufts University.

Alexandra Pelletier

Alexandra Pelletier

Presidential Innovation Fellow
The White House

Alexandra Pelletier has over 15 years of experience aligning business strategy with the development of digital products and services. She is currently a Presidential Innovation Fellow, a program created by the White House in 2012. 

Previously, Ms. Pelletier built digital health innovation programs at adult and pediatric Harvard Medical School affiliated academic medical centers. She served as the first Director of Digital Innovation at Boston Children’s Hospital. At Partners' Center for Connected Health, she was instrumental in launching the first ever connected health platform using a range of digital health technologies to transform the traditional provider-based, in-office care delivery approach. She expanded these programs to create industry partnerships and commercialize internally developed products. The successes led to the broader strategic vision for these academic medical centers to prepare for the future of care delivery. 

Ms. Pelletier was a consultant at IBM Global Services and Deloitte working across industries. She is passionate about leading talented teams to develop technologies that deliver a positive impact for people.

John Conrad

John Conrad

Principal, Regulatory and Operational Risk

John Conrad is an Advisory principal in Deloitte's Life Sciences Regulatory and Operations practice of Deloitte & Touche LLP. He advises his clients on numerous aspects of risk consulting, including assisting organizations in performing company-wide risk assessments to address reputational, financial, operational, regulatory, and IT risks as well as developing sustainable governance frameworks to address those risks. He has significant experience providing technology and regulatory services to numerous global pharmaceutical organizations with a focus on IT GxP compliance/computerized system validation, data privacy and protection, cyber security, GRC technologies, risk and regulatory analytics, Sarbanes Oxley compliance, Transparency/Sunshine Act, and health care compliance and ethics.

Mr Conrad has a bachelor degree in Business Administration from Loyola University, MD.

Gary Capistrant

Gary Capistrant

Chief Policy Officer
American Telemedicine Association

Gary Capistrant's expertise in health policy is based on over 30 years experience with Medicare, Medicaid, and national health reforms. Mr Capistrant's knowledge of health policy has lead him to become a trusted advisor to associations, innovative health providers and Wall Street investment analysts.  He is also the former Director of Congressional Relations for the American Health Care Association, Staff Director of the State Medicaid Directors Association and Health Legislative Assistant for former Rep. Jim Corman.

Mr Capistrant earned a MA in Public Affairs from the Humphrey Institute at the University of Minnesota and he also earned a BA from the same University.

Jon  Zimmerman

Jon Zimmerman

Global Chief Technology Officer and General Manager for Clinical Business Solutions
GE Healthcare

Jon Zimmerman was previously at Availity, where he served as the General Manager of Clinical Solutions, leading the strategic development, planning and delivery of clinical information exchange via the Availity® Health Information Network.
He began his career with IBM, earning numerous awards for innovation and engineering, and qualifying for the top sales honors at the company. Later, at Siemens SMS, he was instrumental in developing and operating HDX, an early leader in healthcare electronic data interchange and in partnership with colleagues there, holds a patent in Revenue Cycle Management. He has also held executive management and product development roles at CareFusion, (a medical device spin-off of Cardinal Health) and served as Senior Vice President of Solutions Management at Allscripts.

He served as the National Co-Chair of the Data Harmonization and Interchange of the WEDI Report 2013. He has participated on many boards of directors in the health information network industry, including the Workgroup for Electronic Data Interchange (WEDI), eHealth Initiative; and the National Alliance for Health Information Technology (NAHIT).

He earned his BA degree from West Chester University of Pennsylvania.

Reena Pande

Reena Pande

Chief Medical Officer and Acting CEO

As a practicing cardiologist, Reena Pande is acutely aware of the critical need for innovative ways to help patients achieve meaningful behavior change. As Chief Medical Officer of AbilTo, she serves as a passionate voice for the need to bridge the gaps between medical health and behavioral health.

Dr Pande also spearheads AbilTo’s data analytics and outcomes research. In addition to her work at AbilTo, she is a practicing cardiologist at Brigham and Women’s Hospital in Boston, MA and Instructor at Harvard Medical School. She earned her undergraduate degree in Biology from Harvard University, her MD degree from Harvard Medical School and a Master’s degree in Epidemiology from the Harvard School of Public Health. She completed her internship, residency training, and fellowship in Cardiovascular Disease and Vascular Medicine at Brigham and Women’s Hospital in Boston, MA.

Samir Malik

Samir Malik

Co-founder and CEO

Samir Malik is Co-founder and CEO of 1DocWay, which enables psychiatrists to interact face-to-face with patients in remote and rural settings. 1DocWay has served over 25,000 patients to date. Previously he was Director of Strategic Planning at CenterPointe Hospital, where he redesigned and expanded the hospital's line of outpatient clinics. Mr Malik started his career as a Business Analyst at McKinsey & Co, focused on hospitals and health insurance companies. He is a graduate of The Wharton School at the University of Pennsylvania.

Cathy Lester

Cathy Lester

Managing Principal, Enterprise Solutions

Cathy Lester is an executive consulting partner in Verizon’s professional services team where she provides technical, business and break-thru ideation for Verizon’s healthcare, insurance and public policy clients. With over twenty years of healthcare experience, Ms Lester provides executive level counsel and complex business case development that create strategic opportunities for Fortune 100 companies.

In her personal time, Ms Lester leads a NATO team working to establish an international telehealth platform under the Science for Peace and Security as well as serving on the Board of Directors for the Unity Alliance focusing on awareness around adolescent vaccinations.

She holds a master’s degree in telecommunications from the University of Denver. Along with completing her post graduate certification in Health Informatics from the University of Illinois Chicago, Ms Lester is pursuing her doctorate in Public Health.

Mike Rhodin

Mike Rhodin

Senior Vice President
IBM Watson and IBM Watson Health

Mike Rhodin is Senior Vice President, IBM Watson and IBM Watson Health. Watson is one of IBM’s most significant innovations in the company’s 103-year history and represents a new era of information technology. IBM Watson is charged with accelerating a new class of “cognitive” software, services and apps that will fuel a diverse cloud-based ecosystem of enterprises, academic institutions and entrepreneurs. Before heading up Watson, Mr Rhodin led the Software Solutions Group delivering industry-specific solutions in high-growth areas such as Business Analytics, Smarter Commerce, Smarter Cities and Social Business.

Throughout his 30 years at IBM, Mr Rhodin’s career has been infused with a passion for helping clients extract value from their technology investments, improving their business performance, and simplifying the way people work.

He has held a number of general management positions across IBM, including the software business where he led the introduction of IBM's social business platform, which IDC has deemed #1 for four years in a row. Mr Rhodin was also instrumental in helping build IBM’s globally integrated enterprise when he lead IBM Northeast Europe, which included Germany, UK, Switzerland, Austria and the Nordics.

A major champion of technology and IBM’s advancements in the industry, he has delivered a number of speeches worldwide, including Carnegie Endowment for International Peace and Harvard Law School. He also serves on the University of Michigan Computer Science and Engineering National Advisory Board.

Mr Rhodin joined IBM in 1984 after he graduated from the University of Michigan with a Bachelor of Science degree in Computer Science.

Cary Gunn

Cary Gunn


Cary Gunn is the President, Chief Executive Officer and Founder of Genalyte.  Dr Gunn currently holds 81 issued US patents, with more in process.  In 2003, he was recognized by MIT Technology Review as a Top Young Innovator. In 2008, he received the Optical Society of America Adolph Lomb medal and the Berthold-Leibinger Foundation Innovation Prize. Dr Gunn also co-founded Luxtera where he was responsible for technology development and served as Chief Technology Officer until 2007.

Dr Gunn received his PhD from Caltech in Electrical Engineering. Before that he was an officer in the US Air Force, responsible for launching GPS satellites. He is a graduate of the US Air Force Academy.


Chaired by (2)

Tim Bradshaw

Tim Bradshaw

Global Technology Correspondent
Financial Times

Tim Bradshaw has been covering the technology industry for 15 years, including leading the FT's reporting on Apple, Uber, Snap and other Silicon Valley companies from San Francisco and Los Angeles, and spotting trends from VR and AR to autonomous vehicles and electric scooters. Now based in London, he covers innovations from the US, Europe and Asia, examining how technology is transforming other industries.

David  Crow

David Crow

Senior US Business Correspondent
Financial Times

David Crow is a Senior US Business Correspondent for the Financial Times, covering telecoms, technology, and pharmaceuticals. He is based in New York. He previously worked on the FT's main news desk in London, where he edited the front page of the print edition. Before joining the FT he was Managing Editor of City AM, the London financial newspaper.

Mr Crow has an MA in English Literature from the University of Glasgow.

Photos from 2015 Summit


To view photos from the 2015 Summit, click here.


Why Attend?

  • Gain insight into what large-scale investors are looking for when it comes to digital health opportunities
  • Hear how leading life science and pharmaceutical companies are focusing on their strategies for growth within this sector 
  • Meet and hear from senior executives in healthcare organisations looking to invest in new digital solutions 
  • Identify digital healthcare delivery trends through a unique 'CMO only' panel discussion
  • Validate the economics of digital health and how consumers are likely to react to its inception

Agenda - 28th Oct

  • 8:00am
    Registration and breakfast
  • 9:05am
    Opening remarks from the Chair

    David Crow, Senior US Business Correspondent, Financial Times

  • 9:10am
    Stakeholder panel: The U.S. digital health leaders forum

    The US market continues to take the lead in healthcare technology and innovation. As global technology corporations increase their activity within the space and whilst innovation and venture capital continues to grow in this market, stakeholders are becoming concerned with how healthcare facilities, regulations and professionals will be able to successfully uptake this technology and data. In order for an effective transition period to take place, the industry must first address the likely challenges to occur. The opening panel of leading stakeholder voices from US healthcare, life sciences, pharmaceuticals and technology providers will share their various perspectives on this inevitable transition.

    • Where will continued drive in digital health come from? Consumers or the industry?
    • How will new technologies change the way healthcare data is used and managed?
    • The role of ‘big data’ in healthcare delivery
    • Mapping the macro-business trends impacting the digital health ecosystem

    Daniel Kraft, Medicine and Neuroscience Chair, Singularity University
    Deborah Waterhouse, Senior Vice President, Primary Care, GSK
    David Rhew, Chief Medical Officer and Head of Healthcare and Fitness, Samsung Electronics America

    Moderated by Tim Bradshaw, San Francisco Correspondent, Financial Times

  • 10:00am
    CMO Panel: Forecasting future healthcare delivery in the USA

    As healthcare becomes more unaffordable and technology continues to capture public imagination, new healthcare delivery models are starting to take shape. The whole future delivery system for healthcare is undergoing change and this is due to technology and digital data. This panel, featuring industry-leading Chief Medical Officers, will determine the future impact of data and technology when it comes to everyday health care practices.

    • Are healthcare systems now moving closer to the patient?
    • How long will the traditional face-to-face doctor-patient relationship last?
    • What’s the likely timeline until patients have dominant control of their own care and their own medical data?
    • How will medical professionals keep up with constantly changing technological trends?

    Harry Leider, Chief Medical Officer and Group Vice President, Walgreens
    Alan Muney, Chief Medical Officer, Cigna
    Andrew Racine, Senior Vice President and Chief Medical Officer, Montefiore Medical Center and Executive Director, Montefiore Medical Group

    Moderated by David Crow, Senior US Business Correspondent, Financial Times

  • 10:50am
    Networking break
  • 11:20am
    Keynote address

    Ryan Olohan, National Industry Director - Healthcare, Google

  • 11:40am
    Investment panel: Attracting the full range of investment formats for digital health development

    As larger corporations move into the sector and digital data continues to gather pace, it is highly likely that the digital health industry will now start to scale up. Will companies finally be able to crack this market and accelerate growth? If they are then investors will need to play a key role in order to make sure that this growth is scalable and commercial. There has been much start-up innovation in this sector, particularly in the US where venture capitalists have played significant roles in helping digital health technologies catch the consumer eye but what would the impact be when private equity and investment bankers join the game?

    • Now that leading technology corporations are moving into the digital health space, what interest do investment bankers now have?
    • How do investors now view the bottom line in light of digital health uptake?
    • What are the main threats from reimbursement risk?
    • Which stakeholder sector are investors eyeing up and why?

    Jody Holtzman, Senior Vice President, Enterprise Strategy and Innovation, AARP
    Lucian Iancovici, Investment Manager - Qualcomm Life Fund, Qualcomm Ventures
    Unity Stoakes, Co-founder and President, StartUp Health

    Moderated by Tim Bradshaw, San Francisco Correspondent, Financial Times

  • 12:20pm
    Panel: Commercializing digital health innovation through best practice business models

    Digital health innovation in the US continues to grow but attention needs to be paid on the business models required based on reimbursement in accordance with the value they bring to public healthcare. In some cases, the business model and reimbursement will be based upon finding ways of effectively driving down costs in the healthcare system, often working in collaboration with key regulatory figures.

    • What are the latest emerging business models?
    • How can incentives be better aligned?
    • Identifying examples of organisations that have been successful in gaining reimbursement for digital health enabled services
    • What are payers looking for in their decision making with regards to reimbursement of digital services?

    Samir Malik, Co-founder and CEO, 1DocWay
    Halle Tecco, Founder and Managing Director, Rock Health
    Reena Pande, Chief Medical Officer and Acting CEO, AbilTo

    Moderated by David Crow, Senior US Business Correspondent, Financial Times

  • 1:00pm
    Networking luncheon
  • 2:00pm
    Regulation panel: What role will technology play in U.S. healthcare reforms?

    Seismic changes have been going on in the US due to the creation of the Affordable Care Act as well as increased cost pressures. In light of the aid that digital health can bring towards this economically, it will inevitably bring with it a whole host of regulatory implications. Forecasting what these implications will be when healthcare migrates onto consumer digital devices will be critical for the effective transition of healthcare services. For example a smart phone can monitor a large range of health conditions but if, due to digital transformation, it turns into a medical device, is it not therefore subject to regulation?

    • Will regulation stifle digital health as has been seen in some other digitalized industries?
    • How will regulation allow for clarity and growth when it comes to defining what is a medical device and what is a health application?
    • Can we avoid regulation stumbling in the way of digital health innovation?
    • How can governments and health services encourage the effective uptake of digital transformation into the health industry?

    Gary Capistrant, Chief Policy Officer, American Telemedicine Association
    Bakul Patel, Associate Director for Digital Health, US Food and Drug Administration (FDA)
    John Conrad, Leader, Life Sciences Regulatory and Risk Services, Deloitte

    Moderated by Tim Bradshaw, San Francisco Correspondent, Financial Times

  • 2:40pm
    Keynote interview: The merger of medicine, healthcare and technology

    Laurie Olson, Executive Vice President, Strategy, Portfolio and Commercial Operations, Pfizer

    Moderated by David Crow, Senior US Business Correspondent, Financial Times

  • 3:10pm
    Innovation panel: Identifying technological success stories and the implementation strategies they require

    From smart pills to 3D bioprinting, to digestible and wearable sensors to nanorobotics and next generation gene sequencing and beyond, the vast array of technologies under development has the potential to completely transform health and medicine.

    • What are the technologies under development?
    • Which have the greatest potential for transformation into healthcare services?
    • Which will make their way into clinical practice?
    • Can they provide evidence in terms of their usability and their ability to reduce costs in healthcare systems?

    Cary Gunn, CEO, Genalyte
    Cathy Lester, Managing Principal, Enterprise Solutions, Verizon
    Babak Parviz, Vice President, Amazon
    Alexandra Pelletier, Presidential Innovation Fellow, The White House
    Jon Zimmerman, Global Chief Technology Officer and General Manager for Clinical Business Solutions, GE Healthcare

    Moderated by Harry Greenspun, M.D., Director, Deloitte Center for Health Solutions

  • 4:10pm
    Closing keynote address

    Mike Rhodin, Senior Vice President, IBM Watson and IBM Watson Health

  • 4:30pm
    Chair’s closing remarks

    David Crow, Senior US Business Correspondent, Financial Times

  • 4:35pm
    Networking drinks reception

Who Attends?

FT Live has a reputation for delivering very senior board level audiences to attend a wide range of world class thought-leadership events across the globe for nearly 40 years. 

The FT Digital Health Summit USA will be attended by: 

CEOs, Chief Medical Officers, CFOs, CTOs, CIOs, Heads of Healthcare, Directors of Innovation, Managing Directors, Healthcare Investment, Technology Directors, Heads of Life Sciences, Heads of Disruptive Innovation, Heads of R&D and other senior executives from the following companies:

  • Life science companies 
  • Pharmaceutical and biotechnology companies 
  • Healthcare providers 
  • Multi-technology corporations 
  • Investment banks 
  • Medical device manufacturers 
  • Health insurers 
  • Health/big data companies 
  • Multi-technology corporations 
  • Venture capitalists 
  • Health regulatory agencies 
  • Mobile app providers 
  • Mobile operators and service providers 
  • Technology consultancies 
  • Management consultancies 
  • Telemedicine companies 
  • Mobile technology manufacturers 
  • Digital health companies 
  • Data integrators/analytics/brokers 
  • Genomics/personalised medicine related companies 
  • Wireless-device manufacturers


The Westin New York at Times Square
270 West 43rd Street
New York NY 10036

United States of America

Tel: +1 212-201-2700


Lead Sponsors (2)

AARP is the nation’s largest nonprofit, nonpartisan organization dedicated to empowering Americans 50 and older to choose how they live as they age. With nearly 38 million members and offices in every state, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands, AARP works to strengthen communities and advocate for what matters most to families with a focus on health security, financial stability and personal fulfillment. AARP also works for individuals in the marketplace by sparking new solutions and allowing carefully chosen, high-quality products and services to carry the AARP name. As a trusted source for news and information, AARP produces the world’s largest circulation publications, AARP The Magazine and AARP Bulletin. To learn more, visit or follow @AARP and @AARPadvocates on social media.

Cigna Corporation (NYSE:CI) and its subsidiaries comprise a global health services and financial company that serves millions of people worldwide through our health, pharmacy, behavioral, dental, disability, life, accident and international products and services. Our mission is to help improve the health, well-being and sense of security of the people we serve.

Associate Sponsors (2)

Genalyte is transforming the doctor-patient relationship by bringing the doctor, the patient, and the lab together to provide results when they matter: Now. By moving data – not blood – our technology provides test results in under fifteen minutes from one drop of blood in the doctor’s office.  This empowers doctors, improves patient lives, and creates a more efficient healthcare system.

Founded in 2007 and commercial since 2013, Genalyte is based on a simple premise: In the 21st century it is unacceptable that doctors, patients and researchers should have to wait days or even weeks for reliable bloodwork results.  Genalyte’s technology, which leverages silicon biosensor technology to digitize blood samples, is already in use by pharmaceutical companies and academic researchers as part of the drug development process. 

By providing diagnostic results at the time and place they are needed – when the patient is sitting in front of the doctor – there is enormous opportunity to transform our healthcare system and improve quality of care for patients while lowering costs.

McLaren Applied Technologies harnesses the significant R&D, technical expertise and innovative spirit that has kept McLaren at the pinnacle of elite motorsport for five decades. It then applies this knowledge and approach to improve the performance of and inspire innovation in blue-chip companies.

Applied Technologies works in a range of industries, often totally unrelated to motorsport or automotive, including healthcare, pharmaceuticals, energy, transportation and consumer brands.

Drawing on our experience of high volume, real time data processing and predictive analytics, we are using biotelemetry technology to remotely monitor and understand clinical trial patients; to facilitate personalised patient care and improve the effectiveness of clinical trials. This is just the start of our journey into tackling global healthcare challenges.

Supporting Organizations (7)

The Digital Health Coalition is a 501(c)(3) nonprofit created to serve as the collective voice and industry rallying point for the discussion of the current and future issues relevant to digital marketing of healthcare products and services. We engage multiple and diverse stakeholders in order to achieve the Digital Health Coalition’s vision of identifying and then recommending specific actions that will drive innovation of digital healthcare communication and engagement for the benefit of the public at large.

The Health Data Consortium (HDC) sits at the intersection of health data, innovation and public policy. HDC is a public-private consortium focused on promoting the accessibility, availability and responsible use of health data and encourages collaboration among health data users and stakeholders to ignite innovation, drive down rising health care costs and improve patient outcomes. We bring together a diverse group of stakeholders including patient advocates, providers, researchers, industry representatives, innovators, and policymakers to advance the national dialogue surrounding the key barriers and opportunities in using health data. Since its formation, HDC has focused on a number of important cultural, technical, and public policy issues concerning health data, including data governance, data accessibility, privacy and security and consumer engagement.

HCPEA is a not-for-profit trade association whose mission is to support the reputation, knowledge, and relationships of the healthcare private equity community.

As the first sector-focused trade association in private equity, HCPEA's 50+ member firms are among the the best known, most respected private equity firms located throughout the United States and Canada. The Association strives to promote a greater understanding of private equity's contribution to the healthcare economy by supporting initiatives that make healthcare an appealing sector for investment, promoting institutional/limited partner investment within the sector, investing in the professional development of our members, and facilitating collaboration between our members and the larger healthcare community.

The International Lawyers Network is an association of 91 high-quality, full-service law firms with over 5,000 lawyers worldwide. The Network provides clients with easily accessible legal services in 67 countries on six continents.

MedTech connects New York State’s Bio/Med industry through collaboration, education and advocacy. We are an active association of over 100 pharmaceutical, biotech and medical technology companies, their suppliers and service providers and research universities. For more than 10 years we have boosted the success and growth of our members. For more information, visit

Northeast Business Group on Health is a network of employers, providers, insurers and other organizations working together to improve the quality and reduce the cost of health care in New York, New Jersey, Connecticut and Massachusetts. Our mission is empowering our members to drive excellence in health and achieve the highest value in healthcare delivery and the consumer experience.

The New York eHealth Collaborative (NYeC) is a not-for-profit organization, working in partnership with the New York State Department of Health to improve healthcare for all New Yorkers through health information technology (health IT).

Founded in 2006 by healthcare leaders, NYeC receives funding from state and federal grants to serve as the focal point for health IT in the State of New York. NYeC develops policies and standards, assists healthcare providers in making the shift to electronic health records, and coordinates the creation of the Statewide Health Information Network of New York (SHIN-NY), a network to connect healthcare providers statewide.


Meredith Vachon
Media Partner & Press Inquiries
Financial Times
Tim Powell
Sponsorship Opportunities
Financial Times
Charlie Hayward
Speaking Opportunities
Financial Times

FT Digital Health Summit Europe

Details of the FT Digital Health Summit Europe can be found HERE.